This inventor holds 1 USPTO granted patent. Top assignee: Diadexus, Inc.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Rajeswari Pillai: Innovator in Colon Cancer Diagnostics and Treatment
Introduction
Rajeswari Pillai is a prominent inventor based in Redwood City, CA (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of colon cancer. Her innovative work has the potential to improve the lives of many patients through advanced diagnostic and treatment methods.
Latest Patents
Rajeswari Pillai holds a patent for a groundbreaking invention titled "Method of diagnosing, monitoring, staging, imaging and treating colon cancer." This invention relates to CSG polypeptides and polynucleotides encoding these polypeptides. It also includes methods for producing the polypeptides, particularly through the expression of the polynucleotides. Furthermore, the invention encompasses agonists and antagonists of the polypeptides, along with methods for utilizing these components in research, diagnostic, and clinical applications. She has 1 patent to her name.
Career Highlights
Rajeswari Pillai is currently associated with Diadexus, Inc., where she continues to advance her research and development efforts. Her work at the company focuses on innovative solutions for cancer diagnostics and treatment, showcasing her commitment to improving healthcare outcomes.
Collaborations
Rajeswari collaborates with various professionals in her field, including her coworker Roberto A Macina. These collaborations enhance her research and contribute to the development of effective medical solutions.
Conclusion
Rajeswari Pillai is a dedicated inventor whose work in colon cancer diagnostics and treatment exemplifies innovation in the medical field. Her contributions are paving the way for advancements that could significantly impact patient care and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
